{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:50:57Z","timestamp":1773348657808,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The present study aimed to investigate the clinical prognostic significance of radiomics signature (R-signature) in patients with gastric neuroendocrine neoplasm (GNEN).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Materials<\/jats:title><jats:p>A retrospective study of 182 patients with GNEN who underwent dual-phase enhanced computed tomography (CT) scanning was conducted. LASSO-Cox regression analysis was used to screen the features and establish the arterial, venous and the arteriovenous phase combined R-signature, respectively. The association between the optimal R-signature with the best prognostic performance and overall survival (OS) was assessed in the training cohort and verified in the validation cohort. Univariate and multivariate Cox regression analysis were used to identify the significant factors of clinicopathological characteristics for OS. Furthermore, the performance of a combined radiomics-clinical nomogram integrating the R-signature and independent clinicopathological risk factors was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The arteriovenous phase combined R-signature had the best performance in predicting OS, and its C-index value was better than the independent arterial and venous phase R-signature (0.803 vs 0.784 and 0.803 vs 0.756, P&amp;lt;0.001, respectively). The optimal R-signature was significantly associated with OS in the training cohort and validation cohort. GNEN patients could be successfully divided into high and low prognostic risk groups with radiomics score median. The combined radiomics-clinical nomogram combining this R-signature and independent clinicopathological risk factors (sex, age, treatment methods, T stage, N stage, M stage, tumor boundary, Ki67, CD56) exhibited significant prognostic superiority over clinical nomogram, R-signature alone, and traditional TNM staging system (C-index, 0.882 vs 0.861, 882 vs 0.803, and 0.882 vs 0.870 respectively, P&amp;lt;0.001). All calibration curves showed remarkable consistency between predicted and actual survival, and decision curve analysis verified the usefulness of the combined radiomics-clinical nomogram for clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The R-signature could be used to stratify patients with GNEN into high and low risk groups. Furthermore, the combined radiomics-clinical nomogram provided better predictive accuracy than other predictive models and might aid clinicians with therapeutic decision-making and patient counseling.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1143291","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:22:43Z","timestamp":1687256563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhi-hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"WHO classification of tumours editorial board. the 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14180","article-title":"Comparison of survival and patterns of recurrence in gastric neuroendocrine carcinoma, mixed adenoneuroendocrine carcinoma, and adenocarcinoma","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"All other frascati consensus conference participants; European neuroendocrine tumor society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.08.004","article-title":"Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma","volume":"42","author":"Xie","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the united states","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0027","article-title":"Are G3 ENETS neuroendocrine neoplasms heterogeneous","volume":"20","author":"V\u00e9layoudom-C\u00e9phise","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0119","article-title":"Other knowledge network members. characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30438-2","article-title":"The TNM classification of malignant tumours-towards common understanding and reasonable expectations","volume":"18","author":"O'Sullivan","year":"2017","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-0924-6","article-title":"The ENETS and AJCC\/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement","volume":"456","author":"Kl\u00f6ppel","year":"2010","journal-title":"Virchows Arch"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9206","article-title":"Extent of arterial tumor enhancement measured with preoperative MDCT gastrography is a prognostic factor in advanced gastric cancer after curative resection","volume":"201","author":"Komori","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.21037\/atm.2019.09.114","article-title":"Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors","volume":"7","author":"Yan","year":"2019","journal-title":"Ann Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx055","article-title":"The rise of radiomics and implications for oncologic management","volume":"109","author":"Verma","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08704-8","article-title":"Radiomics in precision medicine for gastric cancer: opportunities and challenges","volume":"32","author":"Chen","year":"2022","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8919","article-title":"The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer","volume":"7","author":"Liang","year":"2016","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/npjbcancer.2016.12","article-title":"Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA\/TCIA data set","volume":"2","author":"Li","year":"2016","journal-title":"NPJ Breast Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/60\/14\/5471","article-title":"A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities","volume":"60","author":"Vallieres","year":"2015","journal-title":"Phys Med Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.671420","article-title":"Radiomics analysis of contrast-enhanced CT predicts survival in clear cell renal cell carcinoma","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.315","article-title":"Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms","volume":"117","author":"Fang","year":"2017","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01119-8","article-title":"Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine\/mixed adenoneuroendocrine carcinoma","volume":"24","author":"Zheng","year":"2021","journal-title":"Gastric Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.crad.2016.09.013","article-title":"Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging","volume":"72","author":"Sala","year":"2017","journal-title":"Clin Radiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"Zhang","year":"2014","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.01.050","article-title":"Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging","volume":"70","author":"Rutman","year":"2009","journal-title":"Eur J Radiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109662","article-title":"Radiomics analysis of CT imaging for differentiating gastric neuroendocrine carcinomas from gastric adenocarcinomas","volume":"138","author":"Wang","year":"2021","journal-title":"Eur J Radiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/00365521.2021.1984571","article-title":"Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms","volume":"57","author":"Liao","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31828ff59d","article-title":"Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis","volume":"37","author":"Ishida","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i3.516","article-title":"Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas","volume":"23","author":"Liu","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000443172","article-title":"Vienna Consensus conference participants. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas","volume":"103","author":"Garcia-Carbonero","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2258-0","article-title":"Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms","volume":"472","author":"Kl\u00f6ppel","year":"2018","journal-title":"Virchows Arch"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20616","article-title":"Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of e-cadherin and ki-67 as prognostic markers","volume":"95","author":"Boo","year":"2007","journal-title":"J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i46.8687","article-title":"Metastatic type 1 gastric carcinoid: a real threat or just a myth","volume":"19","author":"Grozinsky-Glasberg","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.32074\/1591-951X-229","article-title":"Neuroendocrine neoplasms of the esophagus and stomach","volume":"113","author":"Mastracci","year":"2021","journal-title":"Pathologica"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0059","article-title":"Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter data","volume":"14","author":"Wei","year":"2018","journal-title":"Future Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10293-7","article-title":"Gastric neuroendocrine tumors: reappraisal of type in predicting outcome","volume":"28","author":"Hanna","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/0284185117725367","article-title":"Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis","volume":"59","author":"Choi","year":"2018","journal-title":"Acta Radiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.677814","article-title":"Development of CT-based imaging signature for preoperative prediction of invasive behavior in pancreatic solid pseudopapillary neoplasm","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.744311","article-title":"A novel clinical-radiomics model based on sarcopenia and radiomics for predicting the prognosis of intrahepatic cholangiocarcinoma after radical hepatectomy","volume":"11","author":"Deng","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1143291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:22:46Z","timestamp":1687256566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1143291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":41,"alternative-id":["10.3389\/fonc.2023.1143291"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1143291","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"article-number":"1143291"}}